NASDAQ$SPRB
Spruce Biosciences Inc · Q2 2022 earnings
Q2 2022 earnings ·
Headline financials
Revenue & EPS history
Spruce Biosciences Inc · Revenue · Quarterly
$0
Q2 2022
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 14 quarterly earnings reports · overlaid with Q2 2022
-1.7%
Avg return
Earnings day
-1.5%
Avg return
5 days after
-0.6%
Avg return
30 days after
27%
4 / 15 earnings
Positive
+6.1%
Q3 2022
Best reaction
-10.5%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | +2.1% | -9.3% | -9.5% | |
| Q3 2025 | -2.6% | -8.0% | -23.5% | |
| Q2 2025 | -5.9% | -4.2% | +33.3% | |
| Q1 2025 | -1.4% | +4.2% | -9.7% | |
| Q3 2024 | -1.3% | -7.9% | -27.4% | |
| Q2 2024 | -4.6% | +3.2% | +7.3% | |
| Q1 2024 | -3.4% | -10.0% | -20.2% | |
| Q3 2023 | +2.9% | +28.6% | +65.7% | |
| Q2 2023 | -1.6% | +5.6% | +11.9% | |
| Q1 2023 | -2.2% | +4.5% | +6.3% | |
| Q3 2022 | +6.1% | +6.1% | +3.0% | |
| Q2 2022 | +1.0% | +10.8% | -7.2% | |
| Q1 2022 | -10.5% | -6.3% | +8.4% | |
| Q3 2021 | -1.9% | -34.5% | -44.1% | |
| Q2 2021 | -2.2% | -5.2% | -3.2% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro